Company Valuation: InnoCan Pharma Corporation

Data adjusted to current consolidation scope
Fiscal Period: December 2019 2020 2021 2022 2023
Capitalization 1 17.75 49.04 157.1 39.67 62.91
Change - 176.32% 220.33% -74.75% 58.58%
Enterprise Value (EV) 15.85 46.74 146 34.76 59.06
Change - 194.95% 212.46% -76.2% 69.91%
P/E ratio -4.46x -4.28x -14.1x -10.5x -12.8x
PBR 12.6x -13.7x 17.3x 6.2x 15.3x
PEG 0.1x -0x 0.5x 0.2x -0.6x
Capitalization / Revenue - 6,129,831,561x 801,464,473x 15,502,545x 4,606,415x
EV / Revenue - 5,842x 745x 13.6x 4.32x
EV / EBITDA -5.29x -9.98x -19.6x -5.58x -15.7x
EV / EBIT -0x -0x -0x -0x -0x
EV / FCF -16.4x 15.6x -19.7x -5.57x -82x
FCF Yield -0% 0% -0% -0% -0%
Dividend per Share 2 - - - - -
Rate of return - - - - -
EPS 2 -0.0276 -0.0614 -0.0447 -0.0151 -0.0183
Distribution rate - - - - -
Net sales - 0.008 0.196 2.559 13.66
EBITDA -2.998 -4.685 -7.437 -6.231 -3.77
EBIT 1 -3.001 -4.725 -7.48 -6.266 -3.803
Net income 1 -3.335 -9.953 -10.05 -3.764 -4.7
Net Debt -1.901 -2.3 -11.05 -4.913 -3.852
Reference price 2 0.1234 0.2629 0.6322 0.1589 0.2347
Nbr of stocks (in thousands) 143,866 186,523 248,490 249,728 268,002
Announcement Date 4/8/20 3/31/21 3/31/22 3/30/23 4/1/24
1USD in Million2USD
Estimates

Add to a list
P/E ratio EV / Sales EV / EBITDA Yield Capi. ($)
57.77x14.92x41.72x+0.72%653B
21.23x4.11x12x+3.24%354B
25.72x9.14x18.41x+1.90%353B
38.17x6.45x14.22x+3.63%303B
13.9x4.23x10.08x+3.11%248B
15.8x3.77x9.81x+3.71%234B
24.7x4.3x13.46x+2.33%207B
17.88x4.15x10.6x+3.88%195B
14.97x3.29x8.35x+6.34%149B
Average 25.57x 6.04x 15.41x +3.21% 299.53B
Weighted average by Cap. 31.11x 7.61x 19.74x +2.67%
See all sector valuations

Year-on-year evolution of the PER

evolution-chart INNOCAN-PHARMA-CORPORATIO

Historical PBR trend

evolution-chart INNOCAN-PHARMA-CORPORATIO

Evolution Enterprise Value / Sales

evolution-chart INNOCAN-PHARMA-CORPORATIO

Change in Enterprise Value/EBITDA

evolution-chart INNOCAN-PHARMA-CORPORATIO
  1. Stock Market
  2. Equities
  3. INNO Stock
  4. Valuation InnoCan Pharma Corporation